CRH plc · CRH · FY2025 Q2 · Calendar Q3 2025
CRH: Record Q2, raised guidance and continued growth investment
The supplied analysis supports a constructive operating thesis for CRH: record Q2 performance, raised EBITDA guidance, infrastructure demand, pricing momentum and acquisitions provide evidence of earnings growth. The thesis remains conditional on execution, regulatory approval, continued infrastructure funding and resilience in volumes and pricing.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about CRH FY2025 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, management moved from maintained to raised guidance, reported record Q2 revenue, EBITDA and margins, and increased emphasis on growth capital expenditure, modernization and the pending Eco Material acquisition.
Guidance delta
Raised: full-year 2025 adjusted EBITDA guidance moved to $7.5–$7.7 billion from the prior $7.3–$7.7 billion range.
Key takeaways
- Management described record Q2 revenue, EBITDA and margins.
- Infrastructure demand and pricing momentum remain key growth drivers in the supplied analysis.
- M&A and growth capital expenditure are central to the expansion plan.
- The Eco Material acquisition remains subject to regulatory approval.
- The main debate is whether volume, pricing and infrastructure demand can offset residential and macro risks.
Management priorities
- Execute the Eco Material acquisition, subject to regulatory approval.
- Modernize aggregate facilities in Indiana, Ohio and Texas.
- Continue bolt-on acquisitions and invest in growth capital expenditure.
- Expand connected roads and water, energy and communications services.
Follow CRH with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 8, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Oct 5, 2026 |
| Truist Securities | Buy | Buy | Maintain | Oct 5, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 2, 2026 |
| UBS | Buy | Buy | Maintain | Sep 22, 2026 |
| Stephens & Co. | Overweight | Overweight | Maintain | Jul 31, 2026 |
| Jefferies | Buy | Buy | Maintain | Jun 26, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Mar 3, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Mar 2, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | Nov 12, 2025 |
| RBC Capital | Outperform | Outperform | Maintain | Nov 7, 2025 |
| Barclays | Overweight | Overweight | Maintain | Oct 20, 2025 |
| Bernstein | Outperform | Outperform | Maintain | Sep 11, 2025 |
| Stifel | Hold | Buy | Downgrade | Apr 15, 2024 |
| Redburn Partners | Buy | Neutral | Upgrade | Jan 3, 2023 |
| Berenberg | Hold | Hold | Maintain | Jan 14, 2021 |
| Canaccord Genuity | Buy | Hold | Upgrade | Nov 2, 2016 |
| Societe Generale | Hold | Buy | Downgrade | Aug 26, 2016 |
| Bank of America | Neutral | Underperform | Upgrade | Apr 25, 2016 |
| B of A Securities | Neutral | Underperform | Upgrade | Apr 24, 2016 |
| HSBC | Buy | Hold | Upgrade | Jan 27, 2016 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | Jan 15, 2016 |
Named analyst price targets
Upside is calculated against the persisted previous close $81.46. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Analyst unavailable | $105 | $81.94 | +28.9% | Oct 5, 2026 |
| Wells Fargo | Analyst unavailable | $106 | $81.94 | +30.1% | Oct 5, 2026 |
| UBS | Analyst unavailable | $135 | $88 | +65.7% | Sep 22, 2026 |
| Wells Fargo | Analyst unavailable | $107 | $90.61 | +31.4% | Sep 9, 2026 |
| Berenberg Bank | Harry Goad | $140 | $92.24 | +71.9% | Sep 8, 2026 |
| D.A. Davidson | Garik Shmois | $137 | $95.79 | +68.2% | Aug 24, 2026 |
| Stephens | Analyst unavailable | $125 | $96 | +53.4% | Jul 31, 2026 |
| Wells Fargo | Analyst unavailable | $132 | $106.21 | +62.0% | Jul 8, 2026 |
| Jefferies | Analyst unavailable | $165.6 | $113.05 | +103.3% | Jun 26, 2026 |
| Morgan Stanley | Angel Castillo | $139 | $116.19 | +70.6% | Apr 15, 2026 |
| D.A. Davidson | Analyst unavailable | $120 | $125.17 | +47.3% | Feb 20, 2026 |
| Wells Fargo | Analyst unavailable | $133 | $122.46 | +63.3% | Jan 29, 2026 |
| Wells Fargo | Analyst unavailable | $138 | $131.38 | +69.4% | Jan 13, 2026 |
| UBS | Analyst unavailable | $147 | $122.76 | +80.5% | Jan 8, 2026 |
| Morgan Stanley | Angel Castillo | $140 | $123.68 | +71.9% | Dec 10, 2025 |
| Deutsche Bank | Analyst unavailable | $139 | $119.49 | +70.6% | Dec 8, 2025 |
| Barclays | Adam Seiden | $131 | $117.46 | +60.8% | Oct 20, 2025 |
| UBS | Julian Radlinger | $138 | $117.54 | +69.4% | Oct 14, 2025 |
| Morgan Stanley | Analyst unavailable | $134 | $117.85 | +64.5% | Oct 9, 2025 |
| Wells Fargo | Analyst unavailable | $135 | $116.34 | +65.7% | Oct 7, 2025 |
| UBS | Analyst unavailable | $140 | $121.1 | +71.9% | Oct 2, 2025 |
| UBS | Analyst unavailable | $152 | $119.9 | +86.6% | Oct 1, 2025 |
| RBC Capital | Anthony Codling | $108 | $85.78 | +32.6% | Apr 14, 2025 |
| Berenberg Bank | Analyst unavailable | $120 | $102.52 | +47.3% | Feb 28, 2025 |
| Truist Financial | Keith Hughes | $110 | $82.79 | +35.0% | Aug 9, 2024 |
| Morgan Stanley | Cedar Ekblom | $88 | $74.23 | +8.0% | Jul 9, 2024 |
| Truist Financial | Keith Hughes | $100 | $83.44 | +22.8% | May 13, 2024 |
| Truist Financial | Keith Hughes | $81 | $67.5 | -0.6% | Dec 14, 2023 |
Track every rating change on CRH the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCRH plc, together with its subsidiaries, provides building materials solutions in Ireland, the United States, the United Kingdom, rest of Europe, and internationally. It operates through three segments: Americas Materials Solutions, Americas Building Solutions, and International Solutions. The company offers building materials for the construction and maintenance of public infrastructure, and commercial and residential buildings, as well as construction and renovation of transportation infrastructure, critical utility networks, commercial and residential buildings, and outdoor living spaces; paving and construction services; and produces and sells aggregates, cementitious materials, ready mixed concrete and mortars, and asphalt.…
Historical context
All CRH earningsBasic Materials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| RPM RPM International Inc. | FY2027 Q1 · Calendar Q4 2026 | +1.5% | +3.2% | RPM posts record quarter, but input costs narrow the outlook |
| HMY Harmony Gold Mining Company Limited | FY2026 Q4 · Calendar Q3 2026 | 0.0% | -6.2% | Harmony Gold posts record FY2026 while Eva Copper risks remain |
Latest beats and misses
Who reports nextBeat on EPS
Get the CRH recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-10-08T11:30:42.695197+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-08T11:30:42.692189+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-08. For educational purposes only; not investment advice.